These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1662325)

  • 21. The polycarbonate hemodialysis membrane: neutrophil, platelet, complement and chemiluminescence kinetics during first and second use.
    Heierli C; Markert M; Frei J; Lambert PH; Wauters JP
    Blood Purif; 1986; 4(1-3):82-7. PubMed ID: 3730165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of dialyzers used in shortened dialysis.
    Petersen J; Ramsey KD; Kang MS; Yeh IT
    ASAIO Trans; 1989; 35(3):338-40. PubMed ID: 2688714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Citrate anticoagulation does not correct cuprophane bioincompatibility as evaluated by the expression of leukocyte surface molecules.
    Dhondt A; Vanholder R; Waterloos MA; Glorieux G; De Smet R; Lameire N
    Nephrol Dial Transplant; 1998 Jul; 13(7):1752-8. PubMed ID: 9681723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemodialysis leucopenia as an index of membrane biocompatibility.
    Aljama P; Garin JM; Torres A; Martin-Malo A; Moreno E; Perez-Calderon R
    Contrib Nephrol; 1984; 37():129-33. PubMed ID: 6713865
    [No Abstract]   [Full Text] [Related]  

  • 25. Granulocyte-monocyte colony-stimulating factor levels during hemodialysis-induced leukopenia.
    Kolb G; Klausmann M; Eckle I; Müller T; Lange H; Havemann K
    Nephron; 1993; 65(3):466-8. PubMed ID: 8290002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes.
    Degiannis D; Czarnecki M; Donati D; Homer L; Eisinger RP; Raska K; Raskova J
    Am J Nephrol; 1990; 10(4):276-82. PubMed ID: 2240054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biocompatibility criteria in hemodialysis.
    Cordonnier DJ; Forêt M
    Contrib Nephrol; 1989; 71():30-5. PubMed ID: 2680263
    [No Abstract]   [Full Text] [Related]  

  • 28. Platelet-neutrophil interactions during hemodialysis: a proposed biocompatibility approach.
    Stuard S; Bonomini M; Settefrati N; Albertazzi A
    Int J Artif Organs; 1998 Feb; 21(2):75-82. PubMed ID: 9569128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biocompatibility of a new high-permeability modified cellulose membrane for haemodialysis.
    Ward RA; Schaefer RM; Falkenhagen D; Joshua MS; Heidland A; Klinkmann H; Gurland HJ
    Nephrol Dial Transplant; 1993; 8(1):47-53. PubMed ID: 8381935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodialysis urea rebound and membrane biocompatibility: accuracy of Kt/V estimations.
    Navarro JF; del Castillo N; Fernández JL; Macía ML; Méndez ML; Chahin J; García-Nieto V; Gallego E; Mora-Fernández C; García J
    Artif Organs; 1997 Feb; 21(2):91-5. PubMed ID: 9028489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum transcortin levels in patients with chronic hemodialysis.
    De Moor P; Faict D; Verberckmoes R
    Ann Biol Clin (Paris); 1985; 43(3):267-9. PubMed ID: 3927790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of vancomycin in patients undergoing hemodialysis with polyacrylonitrile.
    Torras J; Cao C; Rivas MC; Cano M; Fernandez E; Montoliu J
    Clin Nephrol; 1991 Jul; 36(1):35-41. PubMed ID: 1889149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
    Mrowka C; Heintz B; Sieberth HG
    Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dialysis membranes and PTH changes during hemodialysis in patients with secondary hyperparathyroidism.
    De Francisco AL; Amado JA; Prieto M; Alcalde G; Sanz de Castro S; Ruiz JC; Morales P; Arias M
    Nephron; 1994; 66(4):442-6. PubMed ID: 8015649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Beneficial effect of AN69 membranes on anemia in hemodialyzed patients].
    García Cortés MJ; Sánchez Perales MC; Liébana A; Gil JM; Borrego FJ; Borrego J; Pérez del Barrio P; Serrano P; Pérez Bañasco V
    Nefrologia; 2001; 21(4):370-5. PubMed ID: 11816513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do different dialysis-membranes affect beta 2-microglobulin kinetics during chronic hemodialysis?
    Risler T; Braun N; Hanel KD; Kuhlmann U; Skroch D; Müller GA
    Int J Artif Organs; 1994 Nov; 17(11):581-4. PubMed ID: 7744517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biocompatibility and hemodynamic studies during polycarbonate versus cuprophane membrane dialysis.
    Schohn DC; Jahn HA; Eber M; Hauptmann G
    Blood Purif; 1986; 4(1-3):102-11. PubMed ID: 3730154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers.
    Smeby LC; Widerøe TE; Balstad T; Jørstad S
    Blood Purif; 1986; 4(1-3):93-101. PubMed ID: 3730167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of different dialyzer membranes on serum angiotensin-converting enzyme during hemodialysis.
    Docci D; Delvecchio C; Turci F; Baldrati L; Gollini C
    Int J Artif Organs; 1988 Jan; 11(1):28-32. PubMed ID: 2834297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experience with the multiple use of dialyzers].
    Strokov AG; Poz IaL; Baeva LB; Levitskiĭ ER; Annenkov AE; Rud'ko IA; Kubatiev AA
    Ter Arkh; 1994; 66(6):60-5. PubMed ID: 7940372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.